Active Ingredient
Docusate Sodium 50 mg
Sennosides 8.6 mg
The following Structured Product Label (SPL) was submitted to the FDA by Dispensing Solutions, Inc. for the product Laxacin (NDC 68258-4985). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, keep out of reach of children, directions, inactive ingredients, package/label principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Docusate Sodium 50 mg
Sennosides 8.6 mg
Stool Softener
Laxative
Do not use
Ask a doctor before use if you have
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.
If pregnant or breast feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
LOT#
Exp. Date:
| age | starting dose | maximum dose |
| adults and children 12 years and older | 2 tablets once a day | 4 tablets twice a day |
Other information
Croscarmellose Sodium, D&C Yellow #10, Dextrose, Dicalcium Phosphate, FD&C Yellow #6, Hypromelose, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol, Silica, Sodium Benzoate, Stearic Acid, Titanium Dioxide.
Questions? If you have any questions or comments, or to report an adverse event, please contact (480) 253-9761.
Manufactured for:
Alexso Inc.
Thousand Oaks, CA 91360
NDC 68258-4985-00
* Please review the disclaimer below.